Aptar: iPUMP® Boosts Adherence to SLIT Allergy Treatment Aptar Digital Health, a leader in digital health solutions, is pleased to announce the positive results from the SPEED1 survey, which demonstrate…
Nuclera Boosts eProtein Discovery for Membrane Protein Production Nuclera, a biotechnology company revolutionizing protein expression and optimization, has announced a major enhancement to its eProtein Discovery™ system: a new workflow…
AdvanCell Secures $18M MRFF Grant for Prostate Cancer Therapy AdvanCell, a clinical-stage radiopharmaceutical company pioneering next-generation cancer therapeutics, has been awarded $18 million in funding from the Australian Federal Government…
Future Pak, LLC (“Future Pak”), a Michigan-based pharmaceutical packaging and manufacturing company, has officially announced the submission of two formal acquisition proposals to Theratechnologies Inc. (“Theratechnologies”), a biopharmaceutical company listed…
QIAGEN Surpasses Q1 2025 Outlook, Raises Full-Year EPS Forecast QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced strong preliminary results for the first quarter of 2025, surpassing both…
Sentynl Therapeutics Unveils First Clinical Evidence Supporting NULIBRY® for Molybdenum Cofactor Deficiency Type A Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly owned by Zydus Lifesciences, Ltd., has announced the…
ABEC Unveils Single-Use Bioreactor for Cell Therapy Manufacturing ABEC, a global leader in engineered solutions for biotechnology manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™), a groundbreaking platform designed to…
GeneDx Expands Exome and Genome Testing to Include Inborn Errors of Immunity GeneDx (Nasdaq: WGS), a leader in genomic diagnostics, has announced the expansion of its commercial focus to include…
Utah Fertility Center Hires Dr. Erica Louden and Dr. Melinda Henne Ivy Fertility, a global network of renowned fertility clinics, is excited to announce the addition of Dr. Erica Louden…
AGC Biologics Launches Cellular and Genetic Technologies Division to Boost Nine Market-Approved Products AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO), has announced the creation of its new…
ELIQUENT Life Sciences Acquires Truliant Consulting to Expand Pharmacovigilance Platform ELIQUENT Life Sciences, a global leader in regulatory, quality, and safety consulting, has announced the strategic acquisition of Truliant Consulting,…
Johnson & Johnson Completes Intra-Cellular Therapies Acquisition to Strengthen Neuroscience Leadership Johnson & Johnson (NYSE: JNJ) has officially completed its acquisition of Intra-Cellular Therapies, Inc., further strengthening its position in…